Single-cell assay for transposase-accessible chromatin with sequencing (ATAC-seq) of the BM revealed IL-1β, known to be elevated systemically after stroke, to be a key driver of epigenetic reprogramming in HSPCs post-stroke. This evidence concerns the gene IL1B and stroke disorder.